Yamairi K, Ido K, Nakamura S, Niki M, Imoto W, Shibata W, Namikawa H, Fujimoto H, Yamada K, Nakamae H, Hino M, Kaneko Y, Miyazaki Y, Kakeya H
　Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: A case report

中前美佳
　慢性骨髄性白血病（検査項目と異常値からみた緊急・重要疾患レッドページ）

Fujishima N, Uchida T, Onishi Y, Jung CW, Goh YT, Ando K, Wang MC, Ono C, Matsumizu M, Paccagnella ML, Sleight B, Vandendries E, Fujii Y, Hino M.
　Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia.

Sakatoku K, Takeoka Y, Miura A, Araki T, Fujitani Y, Yamamura R, Nakamae H, Ohta K, Hino M.
　Combination of Frailty Status and Comorbidity Score Improves the Stratification of Survival in Patients With Myelodysplastic Syndrome Owing to Good Predictive Capability for Infection-related Mortality

Nakane T, Okamura H, Tagaito Y, Koh S, Yoshimura T, Makuuchi Y, Nanno S, Nakamae M, Hirose A, Nakashima Y, Koh H, Hino M, Nakamae H
　Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.

Nagafuji K, Matsumura I, Shimose T, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Kadowaki N, Ishikawa J, Imamura Y, Yamazaki H, Akashi K, Kanakura Y
　Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt).

Shinohara A, Oshima K, Fuji S, Umeda K, Kako S, Kurokawa M, Tsukada N, Kasai M, Kondo T, Hashii Y, Nakamae H, Ikegame K, Kosaka Y, Shimada A, Nawa Y, Makoto Y, Yoshiko A, Fukuda T, Tanaka J, Ogata M.
　Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Nakamae H, Fujii K, Nanno S, Okamura H, Nakane T, Koh H, Nakashima Y, Nakamae M, Hirose A, Teshima T, Hino M
　A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.

Nishiwaki S, Mizuta S, Ohashi K, Fukuda T, Uchida N, Tachibana T, Onizuka M, Ozawa Y, Onishi Y, Takahashi S, Eto T, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, Kako S; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
　Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph + ALL with minimal residual disease

Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi K, Uchida N, Tanaka M, Fukuda T, Ozawa Y, Takahashi S, Onizuka M, Shiratori S, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Kako S; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
　Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia

高桑輝人、荒木 拓, 三浦 晃子, 藤谷 洋太朗, 武岡 康信, 太田 健介, 山村 亮介
　再発・難治性多発性骨髄腫に対するイキサゾミブ、レナリドミド、デキサメタゾン併用療法の有効性と安全性の検討

Takakuwa T, Otomaru I, Araki T, Miura A, Fujitani Y, Mochizuki Y, Miyagi Y, Senzaki H, Yamamura R
　The First Autopsy Case of Fatal Acute Cardiac Failure after Administration of Carfilzomib in a Patient with Multiple Myeloma

Nishimoto M, Hirose A, Koh H, Nakamae M, Nanno S, Okamura H, Nakane T, Nakashima Y, Hino M, Nakamae H
　Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Tanaka M, Ohashi K, Ota S, Uchida N, Fukuda T, Nakamae H, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, Ogata M
　BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient

Yano S, Yokoyama H, Yanada M, Mori J, Aoki J, Ohashi K, Kanomori H, Ozawa Y, Sawa M, Nakamae H, Eto T, Ohta S, Tanaka J, Ichinohe T, Atsuta Y, Takami A.
　Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission

中前博久
移行期/急性転化期ＣＭＬ治療の現状

日野雅之
　リンパ系腫瘍と溶血性貧血

Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Takanashi M, Kanda Y, Atsuta Y, Yano S
　Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience

Takakuwa T, Nakashima Y, Koh H, Nakane T, Nakamae H, Hino M
　Short-Term Fasting Induces Cell Cycle Arrest in Immature Hematopoietic Cells and Increases the Number of Naïve T Cells in the Bone Marrow of Mice

Ido K, Nakamae M, Koh H, Okamura H, Nanno S, Nishimoto M, Takeoka Y, Hirose A, Nakashima Y, Hashimoto Y, Nakane T, Hino M, Nakamae H
　The Proportional Relationship between Pre-transplant WT1 mRNA Levels and Risk of Mortality after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Not in Remission

Inose R, Takahashi K, Nanno S, Hino M, Nagayama K
　Calcium Channel Blockers Possibly Delay the Elimination of Plasma Methotrexate in Patients Receiving High-Dose Methotrexate Therapy

高桑輝人、奥野高裕、西本光孝、南野　智、武岡康信、中嶋康博、康　秀男、中根孝彦、鰐淵英樹、日野雅之、中前博久
　同種造血幹細胞移植後にリンパ還流障害による難治性腹水をきたした急性骨髄性白血病

Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, Miyazaki Y, Kanda J, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
　Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma

Fujiwara SI, Kanda J, Tatara R, Ogawa H, Fukuda T, Okumura H, Ohashi K, Iwato K, Ueda Y, Ishiyama K, Eto T, Matsuoka KI, Nakamae H, Onizuka M, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation
　Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation

Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Sawa M, Uchida N, Ota S, Matsushita A, Kanda Y, Nakamae H, Ichinohe T, Kato K, Murata M, Atsuta Y, Teshima T; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation
　Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors

Konuma T, Harada K, Yamasaki S, Mizuno S, Uchida N, Takahashi S, Onizuka M, Nakamae H, Hidaka M, Fukuda T, Ohashi K, Kohno A, Matsushita A, Kanamori H, Ashida T, Kanda J, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
　Upfront allogeneic HCT vs remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: a propensity score matched analysis

Nakamae H
　Current status of HLA haplo-identical transplantation using post-transplantation cyclophosphamidet

アザシチジンを投与中にMycobacterium abscessusによる播種性非結核性抗酸菌症を発症した骨髄異形成症候群
巽　尚子、堤　美奈子、中舎洋輔、吉田全宏、吉村卓朗、林　良樹、中尾隆文、山根孝久

第66回日本臨床検査医学会

O-100
山下　亘、上野信弥、奥井靖子、久保田　浩、中前美佳、日野雅之
ＩＳＯ15189の継続的改善を行うための品質指標の設定

第112回近畿血液学地方会

原発性皮膚ＣＤ８陽性急速進行性表皮向性細胞傷害性Ｔ細胞リンパ腫の一例
中井久実代、中根孝彦、田垣内優美、岡村浩史、南野　智、中前博久、日野雅之、桑江優子、大澤政彦

第81回日本血液学会　

OS3-8A-2
Unit selection for umbilical cord blood transplantation for adults with AML in complete remission
Masamitsu Yanada, Takaaki Konuma, Yachiyo Kuwatsuka, Tadakazu Kondo, Takahito Kawata, Satoshi Takahashi, Naoyuki Uchida, Shigesaburo Miyakoshi, Masatsugu Tanaka, Yukiyasu Ozawa, Masashi Sawa, Hirohisa Nakamae, Nobuyuki Aotsuka, Junya Kanda, Minoko Takanashi, Yoshinobu Kanda, Yoshiko Atsuta, Shingo Yano

OS2-7A-4
Clinicopathological analysis of HIV associated lymphoma at Osaka City General Hospital
Minako Tsutsumi（大阪市立総合医療センター）, Takafumi Nakao, Yosuke Nakaya, Masahiro Yoshida, Takuro Yoshimura, Yoshiki Hayashi, Takeshi Inoue, Takahisa Yamane

PS3-23-3
Case of successful treatment of cryptococcal meningitis by voriconazole complicated by ATL
Kiryang Koh（大阪鉄道病院）, Dai Momose, Shiro Koh, Masahiro Manabe, Yasuyoshi Sugano, Masayuki Hino

PS2-23-8
Elotuzumab therapy combined with lenalidomide and dexamethasone for patients with multiple myeloma
Moe Nomura（大阪府済生会中津病院）, Teruhito Takakuwa, Yumi Kimura, Ippei Otomaru, Akiko Miura, Taku Araki, Yotaro Fujitani, Ryosuke Yamamura

原発性マクログロブリン血症の経過中に後天性血友病Ａを発症した１例
木村友美、中嶋康博、岡山裕介、岡村浩史，南野　智，中根孝彦、康　秀男，中前博久，日野雅之、備後真登

多発性骨髄腫における細胞形態分類と予後との関連性の検討
福山智子、荒木拓、高桑輝人、久鍋明莉、海江田杏奈、中村恒仁、深田恵利奈、山村亮介

第111回近畿血液学地方会

巨脾で発症したアグレッシブNK 細胞白血病の1例
森口　慎、中嶋康博、岡村浩史、南野　智、康　秀男　中根孝彦、中前博久、日野雅之、大澤政彦

招請講演
慢性骨髄性白血病治療の最新情報・最前線
中前博久

臍帯血移植後、ＲＳウイルス肺炎に対してリバビリン投与を行うも致死的な転帰を辿った with MRCの1例
岡山裕介、康　秀男，岡村浩史，南野　智，中嶋康博、中根孝彦、中前博久，日野雅之

当院の輸血部と造血細胞移植コーディネーター（ＨＣＴＣ）で取り組む移植関連業務
蓮輪亮介、屋田龍哉、松本友紀、藤野恵三、梅本由香里、田守昭博、河田則文、日野雅之

当院における血小板輸血不応症例の後方指摘検討
海江田杏奈、福山　智子、��桑　輝人、久鍋　明莉、中村　恒仁、深田　恵利奈 、山村　亮介

O16-1
HLA一致血縁又は非血縁ドナーからの同種移植におけるPTCｙ及びTacを用いたGVHD予防-臨床第2相試験中間解析-
中根孝彦、中前博久、南野　智、岡村浩史、西本光孝、幕内陽介、長崎譲慈、田垣内優美、林　哲哉、原田尚憲、井戸健太郎、酒徳一希、谷澤　直、岡山裕介、森口　慎、廣瀬朝生、中前美佳、中嶋康博、康　秀男、武岡康信、日野雅之

O31-5
HCTCの業務に関するアンケートを通じた地域の現状の把握と課題の検討
梅本由香里、田中里苗、福田隆浩、日野雅之

イブニングセミナー
造血幹細胞移植ドナーの安全性について〜骨髄及びG-CSFを用いた末梢血幹細胞採取について〜
日野雅之

消化管穿孔により診断に至った弧発性骨髄肉腫
芦田郷夢（大阪市立総合医療センター）、中尾隆文、堤　美菜子、中舎洋輔、伏屋帆悠里、堀内美令、吉田全宏、吉村卓朗、林　良樹、山根孝久

ランチオンセミナー
慢性骨髄性白血病〜アドヒアランス向上を目指して〜
日野雅之

服薬アドヒアランス向上のための薬剤師の取り組み
高橋克之

患者自身が病いと治療に向き合い続けるための看護師の取り組み
鶴田理恵